Paloma Wang, Greater China Region

Ranked in 1 Practice Areas

Band 3

Capital Markets: Equity (International Firms)

China

4 Years Ranked

Ranked in Guides

Global 2025

About

Provided by Paloma Wang

Greater China Region

Practice Areas

Corporate

Professional Memberships

Admitted in Hong Kong and England & Wales. Currently practising in Hong Kong.

Publications

Recent publications include:

HKEX and SFC Reduce Barriers for Specialist Technology Company IPOs and De-SPACs, August 2024;

HKEX Consults on New Corporate Governance Reforms, July 2024

HKEx Publishes Consultation Conclusions on Enhancing Climate-Related Disclosure, May 2024

HKEx Announces Consultation Conclusion for New Treasury Shares Rules, April 2024

Personal

Paloma Wang is co-head of the firm’s China practice, focusing on public listings and other corporate matters. She represents both issuers and underwriters in initial public offerings on the Hong Kong Stock Exchange, advising investors and corporates on private equity investments and counseling listed issuers on compliance, general corporate and regulatory matters.

Chambers Review

Provided by Chambers

Chambers Greater China Region

Capital Markets: Equity (International Firms) - China

Band 3

Individual Editorial

Paloma Wang wins acclaim for her expertise advising issuers and underwriters on biotech IPOs. She serves a host of clients from Skadden's base in Hong Kong.

Learn more about this team❖View ranking table

Filter by